Pharmacodynamic and Pharmacokinetic Profiles of Prasugrel in Patients With ST Elevation Myocardial Infarction: A Randomized Comparison of Standard Versus Crushed Formulation
Phase of Trial: Phase IV
Latest Information Update: 30 Dec 2016
At a glance
- Drugs Prasugrel (Primary) ; Prasugrel (Primary)
- Indications Myocardial infarction
- Focus Pharmacodynamics
- 18 Mar 2016 Primary endpoint has been met. (Platelet reactivity unit), as per results published in the Journal of the American College of Cardiology.
- 18 Mar 2016 Results published in the Journal of the American College of Cardiology
- 01 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.